OHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual Meeting

Dec 11, 2017 4:04pm EST

Aptose Reports Results for the Third Quarter Ended September 30, 2017

Nov 14, 2017 4:00pm EST

Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017

Nov 07, 2017 8:00am EST

Aptose to Present New CG’806 Data at the 2017 ASH Annual Meeting

Nov 01, 2017 11:14am EDT

Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC

Oct 30, 2017 8:00am EDT

Aptose to Present at the 17th Annual Biotech in Europe Forum

Sep 19, 2017 8:02am EDT

Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806

Sep 12, 2017 8:00am EDT

Aptose Biosciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

Sep 05, 2017 8:30am EDT

Aptose Reports Results for the Second Quarter Ended June 30, 2017

Aug 08, 2017 4:05pm EDT

Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference

Aug 03, 2017 8:30am EDT